Ribosomal protein L17 pseudogene 16 (RPL17P16)

Ribosomal protein L17 pseudogene 16 (RPL17P16) is a processed pseudogene in the human genome that shares sequence similarity with the ribosomal protein L17 gene (RPL17), a component of the 60S ribosomal subunit. Unlike the parent RPL17 gene, RPL17P16 does not encode a functional protein and is presumed to be nonfunctional due to truncations and loss-of-function mutations typically found in pseudogenes. The human genome contains thousands of such ribosomal protein pseudogenes as remnants of past gene duplication and retrotransposition events. RPL17P16 has no known protein product, functional biological activity, direct disease involvement, or drug interactions[1][2][4][11]. Summary of key points: - RPL17P16 is not a therapeutic target, enzyme, receptor, or active coding gene. - It is a processed pseudogene, meaning it is a mutated copy of a ribosomal protein gene rendered nonfunctional[1][4][11]. - No protein product or biological function is attributed to RPL17P16[4]. - No disease association, drugs, or safety considerations are relevant for this locus. If you are seeking information about targets for therapeutic intervention, the parent gene RPL17 (ribosomal protein L17) is a genuine protein-coding gene with defined molecular and cellular roles, but RPL17P16 itself is not functionally relevant[3][5].

Other names

RPL17_4_369RPL17P16[2][9]

None